Fund profile
Fund manager
Total assets
$443.16 mm
Liabilities
$5.57 mm
Net assets
$437.59 mm
Number of holdings
120.00
120 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
AMGN AMGEN Inc. | 40.93 mm | 142.10 k shares | 9.35 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 40.73 mm | 100.10 k shares | 9.31 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 39.10 mm | 44.52 k shares | 8.94 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 32.22 mm | 397.78 k shares | 7.36 | Common equity | Long | USA |
State Street Institutional US Government Money Market Fund | 25.39 mm | 25.39 mm shares | 5.80 | Short-term investment vehicle | Long | USA |
BIIB Biogen Inc | 18.24 mm | 70.49 k shares | 4.17 | Common equity | Long | USA |
AstraZeneca PLC
|
18.21 mm | 270.38 k shares | 4.16 | Common equity | Long | UK |
ALNY Alnylam Pharmaceuticals Inc | 12.09 mm | 63.18 k shares | 2.76 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 10.84 mm | 112.43 k shares | 2.48 | Common equity | Long | USA |
NEUROVANCE MILESTONE INTEREST
|
10.79 mm | 34.05 k shares | 2.47 | Common equity | Long | USA |
MRNA Moderna Inc | 10.72 mm | 107.79 k shares | 2.45 | Common equity | Long | USA |
SPDR Series Trust | 9.35 mm | 104.68 k shares | 2.14 | Common equity | Long | USA |
ILMN Illumina Inc | 8.42 mm | 60.49 k shares | 1.92 | Common equity | Long | USA |
ARGX Argen X SE | 6.71 mm | 17.63 k shares | 1.53 | Common equity | Long | Netherlands |
ASND Ascendis Pharma A/S | 5.77 mm | 45.83 k shares | 1.32 | Common equity | Long | Denmark |
NBIX Neurocrine Biosciences, Inc. | 5.10 mm | 38.69 k shares | 1.17 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 4.82 mm | 50.02 k shares | 1.10 | Common equity | Long | USA |
IMVT Immunovant Inc | 4.57 mm | 108.56 k shares | 1.05 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 4.47 mm | 7.66 k shares | 1.02 | Common equity | Long | USA |
EXEL Exelixis Inc | 4.46 mm | 186.12 k shares | 1.02 | Common equity | Long | USA |
Royalty Pharma PLC
|
4.36 mm | 155.07 k shares | 1.00 | Common equity | Long | UK |
Roivant Sciences Ltd
|
4.26 mm | 379.71 k shares | 0.97 | Common equity | Long | Bermuda |
Alkermes PLC
|
4.15 mm | 149.53 k shares | 0.95 | Common equity | Long | Ireland |
BNTX BioNTech SE | 3.95 mm | 37.46 k shares | 0.90 | Common equity | Long | Germany |
PCVX Vaxcyte Inc | 3.89 mm | 61.92 k shares | 0.89 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 3.81 mm | 12.03 k shares | 0.87 | Common equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 3.74 mm | 7.80 mm shares | 0.85 | Preferred equity | Long | USA |
CYTK Cytokinetics Inc | 3.71 mm | 44.41 k shares | 0.85 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 3.60 mm | 101.20 k shares | 0.82 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 3.34 mm | 14.13 k shares | 0.76 | Common equity | Long | USA |
NTRA Natera Inc | 3.21 mm | 51.31 k shares | 0.73 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 3.12 mm | 77.40 k shares | 0.71 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 3.05 mm | 50.99 k shares | 0.70 | Common equity | Long | USA |
BeiGene Ltd
|
3.04 mm | 16.84 k shares | 0.69 | Common equity | Long | Cayman Islands |
HOTSPOT THERAPEUTICS, INC. | 2.83 mm | 1.29 mm shares | 0.65 | Preferred equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 2.83 mm | 39.48 k shares | 0.65 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 2.47 mm | 48.81 k shares | 0.56 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 2.37 mm | 110.33 k shares | 0.54 | Common equity | Long | USA |
ARDX Ardelyx Inc | 2.35 mm | 378.87 k shares | 0.54 | Common equity | Long | USA |
Oculis Holding AG
|
2.24 mm | 203.38 k shares | 0.51 | Common equity | Long | Switzerland |
UTHR United Therapeutics Corp | 2.17 mm | 9.88 k shares | 0.50 | Common equity | Long | USA |
INVETX, INC. | 2.16 mm | 3.23 mm shares | 0.49 | Preferred equity | Long | USA |
XNCR Xencor Inc | 2.07 mm | 97.39 k shares | 0.47 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 2.03 mm | 42.48 k shares | 0.46 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 1.90 mm | 100.88 k shares | 0.43 | Common equity | Long | USA |
MRNS Marinus Pharmaceuticals Inc | 1.82 mm | 167.42 k shares | 0.42 | Common equity | Long | USA |
ETNB 89bio Inc | 1.76 mm | 157.70 k shares | 0.40 | Common equity | Long | USA |
FULC Fulcrum Therapeutics Inc | 1.73 mm | 256.89 k shares | 0.40 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 1.65 mm | 150.42 k shares | 0.38 | Common equity | Long | USA |
AMOLYT PHARMA SAS | 1.62 mm | 686.93 k shares | 0.37 | Preferred equity | Long | France |
MEDP Medpace Holdings Inc | 1.62 mm | 5.28 k shares | 0.37 | Common equity | Long | USA |
Jazz Pharmaceuticals PLC
|
1.61 mm | 13.12 k shares | 0.37 | Common equity | Long | Ireland |
Incendia Therapeutics, Inc. | 1.60 mm | 832.65 k shares | 0.37 | Preferred equity | Long | USA |
NTLA Intellia Therapeutics Inc | 1.54 mm | 50.61 k shares | 0.35 | Common equity | Long | USA |
QUELL THERAPEUTICS | 1.52 mm | 731.12 k shares | 0.35 | Preferred equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 1.48 mm | 32.04 k shares | 0.34 | Common equity | Long | Canada |
TARS Tarsus Pharmaceuticals Inc | 1.46 mm | 72.03 k shares | 0.33 | Common equity | Long | USA |
ENDEAVOR BIOMEDICINES, INC. | 1.40 mm | 296.86 k shares | 0.32 | Preferred equity | Long | USA |
RECODE THERAPEUTICS | 1.39 mm | 150.18 k shares | 0.32 | Preferred equity | Long | USA |
ADPT Adaptive Biotechnologies Corp | 1.35 mm | 275.91 k shares | 0.31 | Common equity | Long | USA |
ABCURO, INC. | 1.27 mm | 232.25 k shares | 0.29 | Preferred equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 1.21 mm | 202.49 k shares | 0.28 | Common equity | Long | USA |
GH Guardant Health Inc | 1.20 mm | 44.54 k shares | 0.28 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 1.17 mm | 129.41 k shares | 0.27 | Common equity | Long | USA |
MREO Mereo Biopharma Group Plc | 1.13 mm | 487.28 k shares | 0.26 | Common equity | Long | UK |
Impact Biomedicines Milestone Preferred Stock | 1.08 mm | 54.33 k shares | 0.25 | Preferred equity | Long | USA |
uniQure NV
|
1.06 mm | 156.39 k shares | 0.24 | Common equity | Long | Netherlands |
CRBU Caribou Biosciences Inc | 1.04 mm | 181.49 k shares | 0.24 | Common equity | Long | USA |
ALXO Alx Oncology Holdings Inc | 985.88 k | 66.21 k shares | 0.23 | Common equity | Long | USA |
INSM Insmed Inc | 935.25 k | 30.18 k shares | 0.21 | Common equity | Long | USA |
INVETX, INC. | 930.00 k | 1.39 mm shares | 0.21 | Preferred equity | Long | USA |
RLYB Rallybio Corp | 901.93 k | 377.38 k shares | 0.21 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 868.42 k | 59.00 k shares | 0.20 | Common equity | Long | USA |
AVTR Avantor Inc. | 846.86 k | 37.09 k shares | 0.19 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 735.34 k | 31.49 k shares | 0.17 | Common equity | Long | USA |
Dynacure SA | 722.54 k | 107.12 k shares | 0.17 | Preferred equity | Long | France |
DHR Danaher Corp. | 720.62 k | 3.12 k shares | 0.16 | Common equity | Long | USA |
BIOTHERYX, INC. SERIES E | 704.00 k | 609.52 k shares | 0.16 | Preferred equity | Long | USA |
GTHX G1 Therapeutics Inc | 681.30 k | 223.38 k shares | 0.16 | Common equity | Long | USA |
ARBOR BIOTECHNOLOGIES | 640.00 k | 38.62 k shares | 0.15 | Preferred equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 623.27 k | 284.12 k shares | 0.14 | Preferred equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 608.36 k | 40.16 k shares | 0.14 | Common equity | Long | USA |
HIBERCELL, INC. SERIES B | 605.07 k | 1.31 mm shares | 0.14 | Preferred equity | Long | USA |
PRIOTHERA LIMITED | 589.36 k | 152.53 k shares | 0.13 | Preferred equity | Long | Ireland |
TMO Thermo Fisher Scientific Inc. | 522.30 k | 984.00 shares | 0.12 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 493.49 k | 22.77 k shares | 0.11 | Common equity | Long | USA |
ARKUDA THERAPEUTICS, INC. | 490.13 k | 447.57 k shares | 0.11 | Preferred equity | Long | USA |
CDXS Codexis Inc. | 489.77 k | 160.58 k shares | 0.11 | Common equity | Long | USA |
IO LIGHT HOLDINIGS, INC. | 453.59 k | 421.63 k shares | 0.10 | Preferred equity | Long | USA |
HLVX HilleVax Inc | 433.35 k | 27.00 k shares | 0.10 | Common equity | Long | USA |
PYXS Pyxis Oncology Inc | 407.98 k | 226.66 k shares | 0.09 | Common equity | Long | USA |
IQV IQVIA Holdings Inc | 381.08 k | 1.65 k shares | 0.09 | Common equity | Long | USA |
OCULIS HOLDING AG
|
366.52 k | 33.32 k shares | 0.08 | Common equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 362.74 k | 362.74 k principal | 0.08 | Debt | Long | USA |
TCRX Tscan Therapeutics Inc | 361.13 k | 61.94 k shares | 0.08 | Common equity | Long | USA |
HIBERCELL,INC. SERIES C | 333.63 k | 719.65 k shares | 0.08 | Preferred equity | Long | USA |
HARP Harpoon Therapeutics Inc | 295.52 k | 25.99 k shares | 0.07 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics Inc | 200.28 k | 62.01 k shares | 0.05 | Common equity | Long | USA |
NKTX Nkarta Inc | 191.32 k | 28.99 k shares | 0.04 | Common equity | Long | USA |
CERCACOR LABORATORIES INC
|
139.89 k | 130.00 k shares | 0.03 | Common equity | Long | USA |
Affimed NV
|
130.39 k | 208.62 k shares | 0.03 | Common equity | Long | Netherlands |
NVAX Novavax, Inc. | 127.74 k | 26.61 k shares | 0.03 | Common equity | Long | USA |
AFFERENT MILESTONE INTEREST
|
121.98 k | 11.23 k shares | 0.03 | Common equity | Long | USA |
CONTRA CHINOOK THERAPE | 96.86 k | 59.06 k shares | 0.02 | Equity derivative | N/A | USA |
Mural Oncology PLC
|
88.52 k | 14.95 k shares | 0.02 | Common equity | Long | Ireland |
ABIO ARCA biopharma Inc | 55.18 k | 32.46 k shares | 0.01 | Common equity | Long | USA |
IMAB I-Mab | 49.61 k | 26.11 k shares | 0.01 | Common equity | Long | Cayman Islands |
PRAX Praxis Precision Medicines Inc | 35.02 k | 1.57 k shares | 0.01 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings Inc | 31.06 k | 5.14 k shares | 0.01 | Common equity | Long | USA |
FUSION PHARMACEUTICALS, INC.
|
28.16 k | 3.26 k shares | 0.01 | Common equity | Long | USA |
INNOVACARE INC
|
19.20 k | 148.15 k shares | 0.00 | Common equity | Long | USA |
GRTX Galera Therapeutics Inc | 18.29 k | 125.77 k shares | 0.00 | Common equity | Long | USA |
TETRAPHASE PHARMACEUTICALS INC | 853.08 | 14.22 k shares | 0.00 | Equity derivative | N/A | USA |
ARKUDA THERAPEUTICS,INC SER A. | 100.88 | 1.01 mm shares | 0.00 | Preferred equity | Long | USA |
Endo International PLC
|
14.55 | 29.10 k shares | 0.00 | Common equity | Long | Ireland |
HIBERCELL, INC. SERIES C | 0.72 | 719.65 k shares | 0.00 | Equity derivative | N/A | USA |
CONTRA SPECTRUM PHARMA | 0.03 | 34.88 k shares | 0.00 | Equity derivative | N/A | USA |
RAINIER THERAPEUTICS, INC. | 0 | 1.69 k shares | 0.00 | Preferred equity | Long | USA |
ETHISMOS RESEARCH, INC. MILEST | 0 | 820.00 shares | 0.00 | Preferred equity | Long | USA |
AMPHIVENA MILESTONE INTEREST | 0 | 100.00 shares | 0.00 | Preferred equity | Long | USA |